ArticleCureus2026
Intradiscal Injection of Minimally Manipulated Adipose Tissue for Disc-Driven Cervical Myelopathy: A Case Report With Three-Year Follow-Up.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical myelopathy is a progressive condition caused by spinal cord compression, for which surgical decompression is considered the standard treatment. However, alternative minimally invasive options are needed for patients who decline surgery. We report the case of a 53-year-old female who presented with progressive hand clumsiness, lower extremity weakness, and gait disturbance. She was diagnosed with cervical myelopathy at three tertiary referral centers, where surgical decompression was recommended, but she declined surgery. Imaging revealed a multilevel disc protrusion with spinal cord compression and signal change. An initial fluoroscopy-guided provocative discography with contrast was performed at C4-5, C5-6, and C6-7. No fluoroscopic evidence of extra-annular leakage was observed. Following intradiscal confirmation, lidocaine was administered as part of the diagnostic procedure, which reproduced the patient's typical symptoms at C4-5 and C5-6 and was followed by temporary symptom relief, thereby identifying the clinically relevant segments. Subsequently, minimally manipulated adipose tissue (MFAT) was injected into the C4-5 and C5-6 discs under fluoroscopic guidance. At six months, follow-up radiographs suggested possible partial restoration of disc space height at the treated levels, although this observation was qualitative and may have been influenced by positional variation. Clinically, the visual analog scale (VAS) improved from 8 to 3, the Neck Disability Index (NDI) improved from 28 to 7, and the modified Japanese Orthopaedic Association (mJOA) score improved from 14 to 18 at one year. Sustained clinical improvement was observed at three-year follow-up. This case suggests that intradiscal MFAT injection may provide sustained clinical improvement, with possible qualitative radiographic interval change, in cervical myelopathy when disc protrusion is the primary contributing factor, and may represent a potential minimally invasive alternative in carefully selected patients who decline surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.